NCT07418671

Brief Summary

The current study was done to evaluate the effect of adding dexamethasone and magnesium sulfate to bupivacaine as adjuvants in an ultrasound-guided erector spinae block for patients undergoing total hip arthroplasty (THA), and to assess their impact on the timing of the first request for analgesia and on overall postoperative analgesic requirements.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P25-P50 for phase_2 postoperative-pain

Timeline
Completed

Started May 2025

Shorter than P25 for phase_2 postoperative-pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2025

Completed
24 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 25, 2025

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

February 8, 2026

Completed
10 days until next milestone

First Posted

Study publicly available on registry

February 18, 2026

Completed
Last Updated

February 18, 2026

Status Verified

February 1, 2026

Enrollment Period

6 months

First QC Date

February 8, 2026

Last Update Submit

February 14, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Post-operative analgesia duration

    Post-operative analgesia duration, which is measured as the time to the first analgesic request by the patient

    24-HOURS

Secondary Outcomes (5)

  • Total postoperative opioid consumption

    12 HOURS

  • Pain Intensity using Visual Analogue Pain Scale (VAS)

    24-HOURS

  • Hemodynamic stability

    24-HOURS

  • Hemodynamic stability

    24-HOURS

  • Postoperative complications

    24-HOURS

Study Arms (3)

Group BS (Bupivacaine-Saline): control

ACTIVE COMPARATOR

Group BS: The group will receive 30 ml 0.25% bupivacaine plus 5 ml normal saline.

Combination Product: Bupivacaine-Saline

Group BM (Bupivacaine-Magnesium)

ACTIVE COMPARATOR

the group will receive 30 mL 0.25% bupivacaine plus 5ml of 10% MgSO4

Combination Product: Bupivacaine-Magnesium Sulphate

Group BD (Bupivacaine-Dexamethasone)

ACTIVE COMPARATOR

The group will receive 30 mL 0.25% bupivacaine plus 5 ml normal saline containing 8 mg dexamethasone.

Combination Product: Bupivacaine-Dexamethasone

Interventions

Bupivacaine plus Magnesium Sulphate (MgSO4) as adjuvant

Group BM (Bupivacaine-Magnesium)
Bupivacaine-DexamethasoneCOMBINATION_PRODUCT

Bupivacaine plus Dexamethasone as adjuvant

Group BD (Bupivacaine-Dexamethasone)
Bupivacaine-SalineCOMBINATION_PRODUCT

Bupivacaine plus Saline as control

Group BS (Bupivacaine-Saline): control

Eligibility Criteria

Age22 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Physical status: ASA 1 or 2.
  • Age \> 21
  • Height 160 to 190 cm.
  • Body Mass Index (BMI) \< 40.

You may not qualify if:

  • Refusing to participate in the study.
  • Coagulopathy.
  • Patients with history of drug allergies to study drugs.
  • Inability to cooperate.
  • Local disease as inflammation or infections at the site of puncture.
  • Uncontrolled diabetes, significant cardiopulmonary disease, and mental illness.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ain Shams University

Cairo, Cairo Governorate, 1181, Egypt

Location

Related Publications (24)

  • Farahata TEM, El-Bahnasawy NS, Heikal O, El-Mohaimen A. Efficacy of adding dexamethasone to levobupivacaine in erector spinae block for total hip arthroplasty. Egypt J Hosp Med. 2022;87(1):2184-2189.

    RESULT
  • Reysner T, Kowalski G, Resyner M, Geisler-Wojciechowska A, Grochowicka M, et al. Erector spinae plane block for pain management after total hip arthroplasty: a systematic review and meta-analysis. Chir Narzadow Ruchu Ortop Pol. 2024;89(4):170-177.

    RESULT
  • Tulgar S, Kose HC, Selvi O, Senturk O, Thomas DT, Ermis MN, Ozer Z. Comparison of ultrasound-guided lumbar erector spinae plane block and transmuscular quadratus lumborum block for postoperative analgesia in hip and proximal femur surgery: a prospective randomized feasibility study. Anesth Essays Res. 2018;12(4):825-831.

    RESULT
  • Hines K, Davis E, O'Shea K, Vogl K. Rehabilitation after total hip arthroplasty. In: Essentials in Total Hip Arthroplasty. Boca Raton (FL): CRC Press; 2024. p. 269-275.

    RESULT
  • Ahmed Mostafa Aref F, Abdelaziz NM, Elazazzi HM, Fahmy NG. Effect of addition of magnesium sulfate and dexamethasone versus plain bupivacaine in ultrasound-guided erector spinae plane block in pediatrics undergoing repair of inguinal hernia. Egypt J Anaesth. 2023;39(1):906-911.

    RESULT
  • Abd El Rahman A, Mohamed M, Hassan A, Mohammed H. Comparative study between dexamethasone-bupivacaine versus magnesium sulfate-bupivacaine for postoperative analgesia. Sohag Med J. 2017;21(3):589-595.

    RESULT
  • Desai N, Kirkham KR, Albrecht E. Local anaesthetic adjuncts for peripheral regional anaesthesia: a narrative review. Anaesthesia. 2021 Jan;76 Suppl 1:100-109. doi: 10.1111/anae.15245.

  • Ban G, Long J, Yan K, Li Q, Huang X, Wei X, Xie F. A New Nanocomposite for Inducing Demineralized Dentin Remineralization. Int J Nanomedicine. 2025 Feb 1;20:1335-1349. doi: 10.2147/IJN.S500283. eCollection 2025.

  • Ratnaparkhi R, Javellana M, Jewell A, Spoozak L. Evaluation of Homologous Recombination Deficiency in Ovarian Cancer. Curr Treat Options Oncol. 2024 Feb;25(2):237-260. doi: 10.1007/s11864-024-01176-6. Epub 2024 Feb 1.

  • Zhang Y, Dong C, Zheng C, Lv Z, Tian RN, Wang M, Chen J, Wang D, Zhang X, Mao Z. Soft-in-Rigid Strategy Promoting Rapid and High-Capacity Lithium Storage by Chemical Scissoring. Inorg Chem. 2024 Jun 17;63(24):11406-11415. doi: 10.1021/acs.inorgchem.4c01493. Epub 2024 Jun 4.

  • Ingendahl M, Vogel T, Topolinski S. The articulatory in-out effect: replicable, but inexplicable. Trends Cogn Sci. 2022 Jan;26(1):8-10. doi: 10.1016/j.tics.2021.10.008. Epub 2021 Oct 30.

  • Wisniewska A, Czepiel K, Stachowicz A, Pomierny B, Kus K, Kiepura A, Stachyra K, Surmiak M, Madej J, Olszanecki R, Suski M. The antiatherosclerotic action of 1G244 - An inhibitor of dipeptidyl peptidases 8/9 - is mediated by the induction of macrophage death. Eur J Pharmacol. 2023 Apr 5;944:175566. doi: 10.1016/j.ejphar.2023.175566. Epub 2023 Feb 3.

  • de la Garza CGV, Narvaez WEV, Rodriguez LDS, Fomine S. Novel 2D allotropic forms and nanoflakes of silicon, phosphorus, and germanium: a computational study. J Mol Model. 2021 Apr 28;27(5):142. doi: 10.1007/s00894-021-04775-4.

  • Chen IY, Chang CW, Fittschen C, Luo PL. Accurate Kinetic Studies of OH + HO2 Radical-Radical Reaction through Direct Measurement of Precursor and Radical Concentrations with High-Resolution Time-Resolved Dual-Comb Spectroscopy. J Phys Chem Lett. 2024 Apr 11;15(14):3733-3739. doi: 10.1021/acs.jpclett.4c00494. Epub 2024 Mar 28.

  • Miele E, Abballe L, Spinelli GP, Besharat ZM, Catanzaro G, Chiacchiarini M, Vacca A, Po A, Capalbo C, Ferretti E. BRAF mutant colorectal cancer: ErbB2 expression levels as predictive factor for the response to combined BRAF/ErbB inhibitors. BMC Cancer. 2020 Feb 17;20(1):129. doi: 10.1186/s12885-020-6586-0.

  • Chan A, Ng TKT, Tang BYH. Single-Shot Lumbar Erector Spinae Plane Block in Total Hip Replacement: A Randomized Clinical Trial. Anesth Analg. 2022 Oct 1;135(4):829-836. doi: 10.1213/ANE.0000000000006162. Epub 2022 Aug 1.

  • Chin KJ, El-Boghdadly K. Mechanisms of action of the erector spinae plane (ESP) block: a narrative review. Can J Anaesth. 2021 Mar;68(3):387-408. doi: 10.1007/s12630-020-01875-2. Epub 2021 Jan 6.

  • Dissanayake K, Godakumara K, Fazeli A. Isolation of Extracellular Vesicles (EVs) Using Size-Exclusion High-Performance Liquid Chromatography (SE-HPLC). Methods Mol Biol. 2021;2273:189-200. doi: 10.1007/978-1-0716-1246-0_13.

  • Roy A, Tewari B, Giri S, Goenka M. Saroglitazar in Non-alcoholic Fatty Liver Disease From Bench to Bedside: A Comprehensive Review and Sub-group Meta-Analysis. Cureus. 2023 Oct 22;15(10):e47493. doi: 10.7759/cureus.47493. eCollection 2023 Oct.

  • Li H, Harvey DH, Dai J, Swingle SP, Compton AM, Sugali CK, Dhamodaran K, Yao J, Lin TY, Sulchek T, Kim T, Ethier CR, Mao W. Characterization, Enrichment, and Computational Modeling of Cross-Linked Actin Networks in Transformed Trabecular Meshwork Cells. Invest Ophthalmol Vis Sci. 2025 Feb 3;66(2):65. doi: 10.1167/iovs.66.2.65.

  • Shambhavi T, Das S, Senapati LK, Padhi PP. Comparative evaluation of bupivacaine with magnesium sulphate and dexamethasone as adjuvants in ultrasound-guided transversus abdominis plane block for open unilateral inguinal hernia surgeries: A randomised controlled trial. Indian J Anaesth. 2023 Apr;67(4):370-375. doi: 10.4103/ija.ija_1091_21. Epub 2023 Apr 10.

  • Rogge N, Janssen J. The Economic Costs of Autism Spectrum Disorder: A Literature Review. J Autism Dev Disord. 2019 Jul;49(7):2873-2900. doi: 10.1007/s10803-019-04014-z.

  • Chin KJ, Adhikary S, Sarwani N, Forero M. The analgesic efficacy of pre-operative bilateral erector spinae plane (ESP) blocks in patients having ventral hernia repair. Anaesthesia. 2017 Apr;72(4):452-460. doi: 10.1111/anae.13814. Epub 2017 Feb 11.

  • Husted H, Lunn TH, Troelsen A, Gaarn-Larsen L, Kristensen BB, Kehlet H. Why still in hospital after fast-track hip and knee arthroplasty? Acta Orthop. 2011 Dec;82(6):679-84. doi: 10.3109/17453674.2011.636682. Epub 2011 Nov 9.

MeSH Terms

Conditions

Pain, Postoperative

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Ashraf A Abouslemah, PhD

    Ain Shams University

    STUDY CHAIR
  • Ahmed F Abdelraouf, PhD

    Ain Shams University

    STUDY DIRECTOR
  • Sameh A Hosny, MSc

    Ain Shams University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 8, 2026

First Posted

February 18, 2026

Study Start

May 1, 2025

Primary Completion

November 1, 2025

Study Completion

November 25, 2025

Last Updated

February 18, 2026

Record last verified: 2026-02

Locations